Get the Stockscreener App
7.00
0.43%
0.03
Journey Medical Corp stock is traded at $7.00, with a volume of 66,673.
It is up +0.43% in the last 24 hours and up +0.00% over the past month.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
See More
Previous Close:
$6.97
Open:
$6.99
24h Volume:
66,673
Relative Volume:
0.69
Market Cap:
$170.06M
Revenue:
$56.13M
Net Income/Loss:
$-14.67M
P/E Ratio:
-9.4595
EPS:
-0.74
Net Cash Flow:
$-9.13M
1W Performance:
+10.24%
1M Performance:
+0.00%
6M Performance:
+60.18%
1Y Performance:
+36.19%
1-Day Range:
$6.80
$7.02
1-Week Range:
$6.22
$7.15
52-Week Range:
$3.535
$8.2487
Journey Medical Corp Stock (DERM) Company Profile
Name
Journey Medical Corp
Sector
Phone
480-434-6670
Address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.00 | 170.06M | 56.13M | -14.67M | -9.13M | -0.74 |
|
RGC
Regencell Bioscience Holdings Ltd
|
20.19 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
155.79 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.42 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.06 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.56 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-28-24 | Resumed | ROTH MKM | Buy |
| Dec-07-21 | Initiated | B. Riley Securities | Buy |
Journey Medical Corp Stock (DERM) Latest News
Journey Medical Corporation (NASDAQ:DERM) Short Interest Up 24.6% in May - MarketBeat
Journey Medical (NASDAQ:DERM) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Wall Street Zen Downgrades Journey Medical (NASDAQ:DERM) to Hold - Defense World
Journey Medical Co. (NASDAQ:DERM) Receives Average Rating of "Buy" from Analysts - MarketBeat
Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand - Yahoo Finance
Journey Medical (DERM) Highlights Emrosi on National TV | DERM S - GuruFocus
Journey Medical announces Emrosi featured on “The Balancing Act” - TipRanks
Birchtech Strengthens Water Treatment Commercialization Team with Strategic Leadership Appointments - The Manila Times
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - Yahoo Finance
44,568 Shares in Journey Medical Co. (NASDAQ:DERM) Acquired by Citadel Advisors LLC - Defense World
Citadel Advisors LLC Takes Position in Mingteng International Co. Inc. (NASDAQ:MTEN) - Defense World
Journey Medical stock soars to 52-week high of $8.25 By Investing.com - Investing.com South Africa
Journey Medical stock soars to 52-week high of $8.25 - Investing.com
Tang Capital Management LLC Buys Shares of 1,725,569 Journey Medical Co. (NASDAQ:DERM) - MarketBeat
Contrasting Amarantus BioScience (OTCMKTS:AMBS) and Journey Medical (NASDAQ:DERM) - Defense World
Q2 EPS Estimates for Journey Medical Reduced by Roth Capital - MarketBeat
Journey Medical Q2 EPS Forecast Decreased by Roth Capital - Defense World
20,455 Shares in Journey Medical Co. (NASDAQ:DERM) Purchased by Dimensional Fund Advisors LP - Defense World
Journey Medical Corporation (NASDAQ:DERM) Q1 2025 Earnings Call Transcript - Insider Monkey
Journey Medical price target lowered to $10 from $10.50 at Alliance Global - TipRanks
Trading Resumes for Journey Medical (DERM) Corp | DERM Stock New - GuruFocus
Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan
Journey Medical (DERM) Surpasses Q1 Revenue Expectations with Su - GuruFocus
Alliance Global Partners Revises Price Target for Journey Medica - GuruFocus
DERM Stock Trading Halted Due to Volatility | DERM Stock News - GuruFocus
Alliance Global Partners Revises Price Target for Journey Medical (DERM) | DERM Stock News - GuruFocus
Journey Medical Corp SEC 10-Q Report - TradingView
Journey Medical Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Journey Medical Q1 2025 reports revenue beat - Investing.com Australia
Journey Medical reports Q1 EPS (18c) vs. (53c) last year - TipRanks
Earnings call transcript: Journey Medical Q1 2025 reports revenue beat By Investing.com - Investing.com UK
Journey Medical earnings missed by $0.08, revenue topped estimates - Investing.com
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Journey Medical Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Journey Medical Corporation Reports First Quarter 2025 Financial Results - TradingView
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Globe and Mail
What To Expect From Journey Medical Corp (DERM) Q1 2025 Earnings - GuruFocus
Care Transition Startup Kouper Lands $10M in Funding - Healthcare Innovation
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Journey Medical (DERM) to Release Quarterly Earnings on Wednesday - Defense World
Dr. Michael Lebow Scholarship Announces Scholarship to Cultivate Future Medical Leaders - Newsfile
Journey Medical (DERM) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 - Stock Titan
Journey Medical (NASDAQ:DERM) Shares Down 1.6%Here's Why - MarketBeat
Top Executives at Journey Medical Corp Make Major Stock Moves! - TipRanks
Journey Medical Co. (NASDAQ:DERM) Shares Sold by Envestnet Asset Management Inc. - Defense World
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Journey Medical Corp Executives Sell Shares to Cover Tax Obligations - TradingView
Journey Medical Co. (NASDAQ:DERM) Short Interest Up 68.0% in April - MarketBeat
McKesson Careers | The future of health starts with you. - McKesson Careers
Journey Medical Corp Stock (DERM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Journey Medical Corp Stock (DERM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Benesch Joseph | CFO |
May 02 '25 |
Sale |
6.84 |
2,409 |
16,478 |
203,557 |
| Alloush Ramsey | COO |
May 02 '25 |
Sale |
6.84 |
2,857 |
19,542 |
504,817 |
| Maraoui Claude | President & CEO |
Mar 11 '25 |
Sale |
5.01 |
49,271 |
246,848 |
2,003,147 |
| Maraoui Claude | President & CEO |
Mar 06 '25 |
Sale |
5.04 |
25,551 |
128,777 |
2,067,323 |
| Maraoui Claude | President & CEO |
Mar 07 '25 |
Sale |
5.01 |
14,905 |
74,674 |
2,052,418 |
| Maraoui Claude | President & CEO |
Mar 04 '25 |
Sale |
5.04 |
28,901 |
145,661 |
2,111,021 |
| Maraoui Claude | President & CEO |
Mar 03 '25 |
Sale |
5.19 |
23,508 |
122,007 |
2,139,922 |
| Maraoui Claude | President & CEO |
Mar 05 '25 |
Sale |
5.13 |
18,147 |
93,094 |
2,092,874 |
| Benesch Joseph | CFO |
Feb 21 '25 |
Sale |
5.19 |
1,365 |
7,084 |
45,966 |
| Benesch Joseph | CFO |
Aug 01 '24 |
Sale |
5.47 |
9,324 |
51,002 |
47,331 |
3.92%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):